Drug Approval | July 15, 2022
U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
MINYM can be safely used by patients above 9 years of age.
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
Lacosamide Injection is used to treat partial-onset seizures.
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
Subscribe To Our Newsletter & Stay Updated
